Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2004-4-9
pubmed:abstractText
In gastric cancer, lymph node metastasis is one of the major prognostic factors and forms the basis for surgical removal of local lymph nodes. Recently, several studies have demonstrated that overexpression of lymphangiogenic growth factor VEGF-C or VEGF-D induces tumor lymphangiogenesis and promotes lymphatic metastasis in mouse tumor models. We examined whether these processes could be inhibited in naturally metastatic tumors by blocking of their cognate receptor VEGFR-3 signaling pathway. Using a mouse orthotopic gastric cancer model which has a high frequency of lymph node metastasis, we estimated lymphatic vessels in gastric cancers by immunostaining for VEGFR-3 and other specific lymphatic markers, LYVE-1 and prox-1. Then we systemically administered anti-VEGFR-3 blocking antibodies. This treatment resulted in the inhibition of regional lymph node metastasis and reduction of lymphatic vessel density in the primary tumors. In addition, increased density of LYVE-1-positive lymphatic vessels of primary tumors was closely correlated with lymph node metastasis in human samples of gastric cancer. Antilymphangiogenesis by inhibiting VEGFR-3 signaling could provide a potential strategy for the prevention of lymph node metastasis in gastric cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1347-9032
pubmed:author
pubmed:issnType
Print
pubmed:volume
95
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
328-33
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:15072591-Adult, pubmed-meshheading:15072591-Aged, pubmed-meshheading:15072591-Aged, 80 and over, pubmed-meshheading:15072591-Animals, pubmed-meshheading:15072591-Antibodies, Monoclonal, pubmed-meshheading:15072591-Cell Line, Tumor, pubmed-meshheading:15072591-Female, pubmed-meshheading:15072591-Glycoproteins, pubmed-meshheading:15072591-Humans, pubmed-meshheading:15072591-Immunotherapy, pubmed-meshheading:15072591-Lymphangiogenesis, pubmed-meshheading:15072591-Lymphatic Metastasis, pubmed-meshheading:15072591-Male, pubmed-meshheading:15072591-Mice, pubmed-meshheading:15072591-Middle Aged, pubmed-meshheading:15072591-Neoplasm Proteins, pubmed-meshheading:15072591-Signal Transduction, pubmed-meshheading:15072591-Stomach Neoplasms, pubmed-meshheading:15072591-Tumor Markers, Biological, pubmed-meshheading:15072591-Vascular Endothelial Growth Factor Receptor-3, pubmed-meshheading:15072591-Vesicular Transport Proteins, pubmed-meshheading:15072591-Xenograft Model Antitumor Assays
pubmed:year
2004
pubmed:articleTitle
Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancer.
pubmed:affiliation
Department of Gastroenterological Surgery, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't